Walensky: FDA working to OK Pfizer, Moderna COVID booster shots for certain immunocompromised patients
The Food and Drug Administration (FDA) is rapidly approaching a potential authorization for a third dose of Pfizer’s and Moderna’s infectious-disease infectious-disease among certain immunocompromised patients, within the next day, Dr. Rochelle Walensky, head of the Centers for Disease Control and Prevention (CDC) said Thursday. “Emerging data show that certain people who are immune compromised,…